Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

MLA

Mercurio, Valentina, et al. “Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-Associated Pulmonary Arterial Hypertension.” American Journal of Respiratory and Critical Care Medicine, vol. 197, no. 3, Feb. 2018, pp. 388–91. EBSCOhost, https://doi.org/10.1164/rccm.201704-0789LE.

APA

Mercurio, V., Mukherjee, M., Tedford, R. J., Zamanian, R. T., Khair, R. M., Sato, T., Minai, O. A., Torres, F., Girgis, R. E., Chin, K., Damico, R., Kolb, T. M., Mathai, S. C., & Hassoun, P. M. (2018). Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 197(3), 388–391. https://doi.org/10.1164/rccm.201704-0789LE

Chicago

Mercurio, Valentina, Monica Mukherjee, Ryan J Tedford, Roham T Zamanian, Rubina M Khair, Takahiro Sato, Omar A Minai, et al. 2018. “Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-Associated Pulmonary Arterial Hypertension.” American Journal of Respiratory and Critical Care Medicine 197 (3): 388–91. doi:10.1164/rccm.201704-0789LE.